Analysis of domestic veterinary drug raw materials market in the 44th week of 2021
Cephalosporins and Penicillins
The prices of ceftiofur sodium and ceftiofur hydrochloride have risen slightly. Since last year, many companies have been put into production one after another. The market supply is relatively sufficient. There is a certain gap in the price of different manufacturers. The price increase in the past year has not been large. Ceftiofur hydrochloride 1865 , Ceftiofur Sodium 2392
Cefquinome Sulfate, the price goes up, the supply is small, the market demand is stable, the price is 8,200
Amoxicillin, the price has risen sharply recently, the market quotation has gradually become clear, the quotation is more than 200
Amoxicillin sodium, market price 465
Potassium amoxicillin and clavulanate, strong momentum, stable trading volume
Ampicillin and Ampicillin Sodium, Strong, Ampicillin Market Price 222, Ampicillin Sodium 285
Penicillin sodium (potassium) rose sharply. The market price of penicillin sodium was 320, and the price of penicillin potassium industrial salt was more than 110. The price of the same period last year was 80, a sharp increase. The price of the same period in 2019 was 61, and the overall trend is increasing year by year.
Aminoglycosides
The price of kanamycin monosulfate has risen sharply recently, and the market has responded quickly. The market price is 305-320. The price of this product will always remain within 300 in 2019 and 2020. This year, the price is outstanding and the price is running at a high level.
Neomycin sulfate has been affected by the market and its price has risen. The quotation is 152-158. At present, market attention has increased, and inquiries and transactions have risen. The price in the third quarter remained at the range of 137-145. In recent years, market competition has been fierce. The overall operation this year is relatively low-key, and the price trend is cautious. Under the "dual control of energy consumption" policy, the price increase has been relatively large. The Asia-Pacific Data Analysis Center focuses on
Spectinomycin hydrochloride, the price has risen, and the manufacturer has stopped taking orders. In recent years, this product has not shown sharpness, low-key operation, dual-control energy consumption and other policy influences, price adjustments, quotations above 590
Gentamicin sulfate, the price rises slightly, the market demand is stable, continue to pay attention to the later trend
Streptomycin sulfate, factory prices increased, limited orders signed, transaction prices rose 265-290
Apramycin sulfate, driven by various factors, increased market attention, and price continued to be concerned
Tetracycline and Chloramphenicol
Doxycycline hydrochloride continues to be high and stable, the price is firm, the supply of goods is relatively balanced, the rhythm of shipments is stable, and the market price is above 700
Oxytetracycline and oxytetracycline hydrochloride were on the strong side, and market inquiries and concerns increased. The transaction price of oxytetracycline was 83-87. Oxytetracycline hydrochloride market price 104-113
Chlortetracycline hydrochloride, slightly up, the market price is 220
Florfenicol, a recent hot product, has experienced a large increase and is beyond the scope of rational acceptance. Purchasing needs to grasp the rhythm. There will be pressure to go up again. The market price is about 700. Asia-Pacific Data Analysis Center focuses on products.
Macrolides
The price of erythromycin thiocyanate increased, and the transaction price was stable at 370-395. The price of the same period in 2020 was 340, an increase of 11.7%. The price of the same period in 2019 was 325. In recent years, the price at its peak was 465 in the same period of 2018.
Tylosin tartrate began to open an upward channel in the third quarter, and the price rose slightly. In October, affected by the dual control policy, the price increase instantly increased, and the market quotation exceeded 310. Tylosin is an intermediate of many products, and its price changes have caused a chain reaction. The price in the same period in 2020 is 235, the price in the same period in 2019 is 240, and the price in the same period in 2018 is 415
Lincomycin hydrochloride has been operating smoothly, and the policy impact has not yet appeared. The transaction price ranged from 332 to 345. The price was strong in the first half of the year. In the second half of the year, affected by the market, the price was slightly weak.
Colistin sulfate, the price is running at a high level, the market price is around 115, the bulk product, the terminal consumption is large, the market transaction is active, and the impact of each price increase on the market is not small. The current price market has been generally accepted. The price of the same period in 2020 is 104, 2019 Same period price 95
Tiamulin fumarate is operating at a high level, the supply is tight, the increase rate has narrowed, the market reaction is dull and rational, and the transaction volume has not increased significantly. The current price is 295-315. The average price in January was 262, rose to 320 in February, 346 in March, 325 in April, and 308 in May. The price continued to fall in June, reaching a low of 260. In July, it began to strengthen at 275. In August, the price rose to 298. In September The price is around 300. Under the dual-control policy in October, we are singing all the way
Tyvanin tartrate, high volatility, sufficient upstream supply, weak terminal market demand, a large gap in market quotation, transaction price 750-792, market transaction price 625 in mid-December last year, the supply began to be tight in the second half of the year, the price has risen continuously, The supply continued to ease until the end of March this year. After April, the supply increased. The transaction price in May was 800-826. The price fluctuated at a high level in June. The price declined in July. The price remained stable since August.
Tilmicosin and Tilmicosin phosphate have a large price increase, and market inquiries are active. The quotation of Tilmicosin is still confusing. The market price is 345 for the same period in 2020 and 341 for the same period in 2019; the market is mostly on the sidelines and transactions The amount is small. Tilmicosin phosphate market offers a wide range of 425-445, an increase of 10.5% month-on-month. The price for the same period in 2020 is 325, an increase of 28.2% year-on-year
Sulfonamides and Quinolones
Sulfonamide products rose collectively, the increase was too fast and the magnitude was large. Under the tight raw materials and the dual control policy, the continuous jump has become unstoppable, and the supply of goods is tight, and the spot must be king. Asia-Pacific Yihe Data Analysis Center focuses on products
Sulfadiazine (sodium), the price rose, due to the dual control policy to limit production and electricity, the quotation increased by 265, the price of the same period last year was 245
Sulfamethazine (sodium), the transaction price goes up, the market price is 120
Sulfamethoxazole (sodium), the price has increased greatly
Sulfonamide versus methoxypyrimidine (sodium), strong operation and active trading
The supply of sulfamonomethoxine (sodium) continues to be tight, and the supply is even more tight due to various factors such as raw material intermediates. Quotes 370-415. The overall performance this year is strong, and the supply is tight, which cannot fully meet the market demand.
Sulfachloropyrazine sodium, the price went up, the transaction price was 374, the price of the same period last year was basically the same in the range of 365-370, and the price of the same period in 2019 was 385
Sulfachlordazine Sodium, the market is stable and the price is high, the market quotation is 348, up 12.2% year-on-year
Sulfaquinoxaline Sodium, the price is rising, the market price is 390
Trimethoprim and trimethoprim lactate have a huge increase and their momentum is like a rainbow. Some areas of trimethoprim lactate are as high as 190, and the price of the same period last year is 179; the ex-factory price of trimethoprim has increased to more than 260, and the ex-factory price of trimethoprim has increased to more than 260 in the same period last year. Up 6.9%
Ditrimethoprim (DVD), the price is too strong to run 390
The prices of quinolones products have repeatedly risen at high levels, manufacturers have stopped reporting and signing, and the trading market has responded quickly. Constrained by the "dual control of energy consumption" power and production restrictions, output is limited, upstream manufacturers are tight, and the spot deadline is extended. Manufacturers have continuously increased their ex-factory prices from September to now.
Enrofloxacin and enrofloxacin hydrochloride have strong prices, and the price of enrofloxacin has increased, and low-priced inventory has decreased. The market price is around 260, and the price of the same period last year was 205, an increase of 26.8%.
The prices of ciprofloxacin lactate and ciprofloxacin hydrochloride went up, the market price was 240, a year-on-year increase of 23.8%, and the price in the same period of 2019 was 195
Sarafloxacin hydrochloride, the price goes up
Marbofloxacin, price strength
Antiparasitic
Diclazuril, the price goes up, the supply is tight, the market price is 1580
The price of Albendazole has risen too fast. This product has maintained a low price for a long time. The recent increase has been rapid. The market quotation is more than 180, slightly higher than the price of the same period last year, and the price of the same period in 2020 is 165. The price of the same period in 2019 is 248, the highest price in June Rising to 276, a historical high, the shortage of supply continued until July 2020, and the price began to fall, falling to less than 200 in August. In the first half of 2021, the overall stability is accompanied by slight fluctuations. In the third quarter, it hovered in the range of 147-157. Entering October, the price began to rise sharply.
Fenbendazole, stable operation, weak market transactions, quotation 349
Abamectin, strong operation, market price 825
Ivermectin, the price goes up, the market price is 1500. The average price in the same period last year was 1,200, and the price in the same period in 2019 was the same as in 2020
Toczuril, the price goes up greatly, the market price is 1470
Levamisole hydrochloride, the price is rising, the supply is tight, the market quotation is about 475, the same month-on-month, an increase of 14.1% year-on-year
Metronidazole, the price goes up, the market price is 87
Dimenidazole, high and strong operation, slow release of upstream sources, slightly tight supply, market quotation is above 120
Praziquantel, the price is rising, the market price is 588
Antipyretic, analgesic, antiasthmatic, improve immunity
Flunixin meglumine, the price is high, the demand is weak, the market price is 950-990
Analgin's price increase was unexpected. Many inquiries were active in the market, and the quotation exceeded 90. The upward attitude was strong. The price rose by 12.5% month-on-month. The price of the same period in 2020 was 70, which was a 15.7% year-on-year increase. The price of the same period in 2019 was 67. Analgin started its upward channel at the end of last year. This year, the overall price has shown an upward pattern. The price in January was 78, and the price fell slightly in March. It maintained stability in April and continued to exert its strength in May. As of now, the market price is above 90.
Acetaminophen continues to rise at a high level, and the market price is above 60, an increase of 48.8% year-on-year
Carbopirin calcium, price upside is unstoppable, quotation 44-49
Taurine, the price goes up, the upward trend is obvious, the transaction price is above 25
Veterinary medicine excipients and other categories
Sodium salicylate, fluctuates upwards, the market price is above 30
Sodium citrate, strong trend
Sodium camphor sulfonate, stable situation, low price
Acephine, the price rises again, the market price is 64-68
Chlorpheniramine, the price is stable and high, the market quotation is above 260, the price of the same period last year is 160
Glucose, the transaction is stable, the tonnage price range is 6350~6800
Jiayi powder, starch, stable transaction
Beta cyclodextrin, stable market quotation 27, a year-on-year increase of 23.4%
Vitamins
VA, the price goes up, the quotation is 320 for mixing material, 330 for water solubility
VB1, price increase, quotation increase, nitric acid 195, hydrochloric acid 280
VB2, recent strong operation, market quotation 80% 107, 98% 357
VB6, the market price rises, some manufacturers stop reporting, and the price is around 195
VB12, price consolidation, market quotation 152-158
VC, stopped falling and rose slightly, currently quoted at 46
VD3, manufacturers increase the upward channel, market quotations increase, attention increases, mixing materials 130, water-soluble 140
VE, strong upward, mixing 95, water-soluble 115
VK3, raw materials are tight, the ex-factory price has risen sharply, and the market quotation has risen by 168-187
Calcium pantothenate, the cost rises, the price rises, the market transaction goes up, the market price is 115
Niacinamide, running smoothly, currently quoted at 55
2% biotin, the price increase is large, the market price is 97
Folic acid, under the dual control policy, the price has risen sharply, and the price is around 375
Looking for chemical products? Let suppliers reach out to you!
2026-07-09
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab
-
Personalized supplements startup VitaminLab raises series A financing
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
The Veterinary Drug Industry is Facing a Period of Opportunity for Change, and Leading Animal Health Companies are Expected to Grow Rapidly
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
-
Vitamin Market Analysis
-
Market Analysis of Veterinary Drug Raw Materials
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
Recommend Reading
-
IPEC Updates Excipient Qualification Guidance
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
BASF Raises API and Excipient Prices
-
April Ethylene Oxide Prices Remain Flat at High Levels
-
Supply-Demand Contradiction Continues, Acrylonitrile Market Prices in China Decline Further
-
Cyclohexane Market Supply Excess, Prices Mainly Stable
-
In April, China's acetone market first declined then rose
-
“Clearing the Floor”: DKSH’s Privatization of Its Malaysian Subsidiary Signals a Silent Power Shift in Asia’s Supply Chain